Home

Evogene Ltd. - Ordinary Shares (EVGN)

2.2600
+1.1300 (100.00%)
NASDAQ · Last Trade: Jun 10th, 6:26 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close1.130
Open2.080
Bid2.050
Ask2.070
Day's Range1.760 - 2.420
52 Week Range0.9500 - 7.190
Volume102,340,735
Market Cap-
PE Ratio (TTM)-
EPS (TTM)-
Dividend & YieldN/A (N/A)
1 Month Average Volume40,305

Chart

About Evogene Ltd. - Ordinary Shares (EVGN)

Evogene Ltd is a biotechnology company focused on enhancing the productivity and sustainability of the agriculture industry through the development of innovative biological solutions. The company leverages advanced computational biology and data-driven approaches to identify and engineer novel traits in plants, aiming to improve crop performance and resilience. By utilizing its proprietary technology platform, Evogene collaborates with industry partners to create products that address critical challenges such as pest resistance, drought tolerance, and nutrient efficiency in various agricultural sectors. Read More

News & Press Releases

Top movers in Tuesday's after hours sessionchartmill.com
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
Via Chartmill · June 10, 2025
Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate Global Expansion of “FOCUSfactor®” Energy Drink – More Stocks Moving Inside
Synergy CHC Corp. (NASDAQ: SNYR), a fast-rising force in the consumer health and wellness space, has appointed Damian Marano as Vice President of Beverage in a strategic move aimed at catapulting the company’s FOCUSfactor Energy Drink into global markets. Marano, a seasoned executive with a decorated history at The Coca-Cola Company (NYSE: KO), brings a wealth of expertise that could unlock powerful international distribution opportunities for the brand.
Via AB Newswire · June 10, 2025
Power Metallic (TSXV: PNPN) (OTCQB: PNPNF) Positioned for Critical Minerals Breakout Following Acquisition – More Stocks Inside
Power Metallic Mines Inc. (TSXV: PNPN) (OTCQB: PNPNF) has executed a deal to acquire 100% of 313 mineral claims from Li-FT Power Ltd., expanding its Quebec land position by over 300% to 212.86 km² . The newly acquired claims border the Company’s flagship Nisk Project, surrounding the high-grade Nisk, Lion, and Tiger polymetallic discoveries.
Via AB Newswire · June 10, 2025
Insights into Evogene's Upcoming Earningsbenzinga.com
Via Benzinga · May 20, 2025
A Glimpse of Evogene's Earnings Potentialbenzinga.com
Via Benzinga · November 20, 2024
Evogene Earnings Previewbenzinga.com
Via Benzinga · March 6, 2024
Dow Gains 50 Points; US Small Business Optimism Index Rises In Maybenzinga.com
Via Benzinga · June 10, 2025
Which stocks are moving on Tuesday?chartmill.com
Intrigued by the market activity in the middle of the day on Tuesday? Uncover the key winners and losers of today's session in our insightful analysis.
Via Chartmill · June 10, 2025
Which stocks are gapping on Tuesday?chartmill.com
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · June 10, 2025
US Stocks Mixed; JM Smucker Shares Plunge After Q4 Resultsbenzinga.com
Via Benzinga · June 10, 2025
Recap: Evogene Q3 Earningsbenzinga.com
Via Benzinga · November 15, 2023
A Preview Of Evogene's Earningsbenzinga.com
Via Benzinga · November 14, 2023
These stocks that are showing activity before the opening bell on Tuesday.chartmill.com
Let's have a look at what is happening on the US markets before the opening bell on Tuesday. Below you can find the top gainers and losers in today's pre-market session.
Via Chartmill · June 10, 2025
Earnings Scheduled For May 21, 2025benzinga.com
Via Benzinga · May 21, 2025
Unusual volume stocks in Tuesday's sessionchartmill.com
On Tuesday, there are stocks with unusual volume. Let's take a look.
Via Chartmill · April 22, 2025
Stocks in Oversold Territory: EVGN, MLGO, PRSO, SHFS – More Undervalued Players Worth Watching Inside
As markets navigate continued volatility, several stocks have entered oversold territory—presenting potential opportunity for value-seeking investors. Below are fast takes on notable names, including Evogene Ltd. (NASDAQ: EVGN), Gulf Resources Inc. (NASDAQ: GURE), Peraso Inc. (NASDAQ: PRSO), MicroAlgo Inc. (NASDAQ: MLGO) and more across biotech, fintech, and industrial segments among others below.
Via AB Newswire · April 22, 2025
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AIbenzinga.com
Evogene's stock surged on news of ICL's acquisition of Lavie Bio's operations, strengthening ICL's position in ag-biologicals.
Via Benzinga · April 21, 2025
Earnings Scheduled For November 21, 2024benzinga.com
Via Benzinga · November 21, 2024
Earnings Scheduled For March 6, 2025benzinga.com
Via Benzinga · March 6, 2025
EVGN Stock Earnings: Evogene Misses EPS, Beats Revenue for Q2 2024investorplace.com
EVGN stock results show that Evogene missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 22, 2024
EVGN Stock Earnings: Evogene Beats EPS, Beats Revenue for Q1 2024investorplace.com
EVGN stock results show that Evogene beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 23, 2024
EVGN Stock Earnings: Evogene Beats EPS, Misses Revenue for Q4 2023investorplace.com
EVGN stock results show that Evogene beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024
Israeli Company Reports Record 2023 Revenue, Wants To Transition Cannabis Operations To 'Third Party'israeli-com
Evogene Ltd. released its fourth-quarter and full-year 2023 financial results, showing a 237% revenue increase for the year. Despite a 12% revenue decrease in Q4, the Israeli cannabis company reported $5.6 million in total revenue for the year. CEO Ofer Haviv highlighted the company's successful collaborations with industry leaders like Corteva, ICL, and Syngenta, contributing to revenue growth. In Q4, gross profit decreased to $180,000, but net financing income rose to $287,000. Total operating expenses increased to $7.8 million, leading to a net loss of $7.3 million. For the full year, gross profit reached $3.9 million, and net financing income was approximately $521,000. Evogene also secured partnerships with Verb Biotics and Colors Farm, along with receiving a €1.2 million EU grant for its Ag-Seed Division's research and development efforts.
Via Benzinga · March 7, 2024
Israeli Cannabis Company Reports Strong Q3 Despite Geopolitical Challengesbenzinga.com
Evogene reports a strong Q3 with $3.8M revenue and significant gross profit growth, showcasing resilience and innovation in cannabis tech.
Via Benzinga · November 16, 2023
Earnings Scheduled For March 7, 2024benzinga.com
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via Benzinga · March 7, 2024